Monitoring of AZA/6-MP treatment in children with IBD is necessary

Inflamm Bowel Dis. 2003 Nov;9(6):386-8; discussion 392-3. doi: 10.1097/00054725-200311000-00007.
No abstract available

MeSH terms

  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use*
  • Child
  • Drug Monitoring*
  • Guanine Nucleotides / analysis
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / blood
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / genetics
  • Mercaptopurine / adverse effects
  • Mercaptopurine / therapeutic use*
  • Methylthioinosine / analysis
  • Methyltransferases / analysis
  • Methyltransferases / genetics
  • Polymorphism, Genetic
  • Thionucleotides / analysis

Substances

  • Guanine Nucleotides
  • Immunosuppressive Agents
  • Thionucleotides
  • 6-thioguanylic acid
  • Methylthioinosine
  • Mercaptopurine
  • Methyltransferases
  • thiopurine methyltransferase
  • Azathioprine